The original article Results of Using Intraoperative Sentinel Lymph Node Identification in the Surgical Management of Stage IA-IIA Non-Small Cell Lung Cancer
##article.numberofdownloads## 54
##article.numberofviews## 210
pdf (Русский)

Keywords

lung cancer
surgical treatment of lung cancer,
signal lymph nodes
ymphatic outflow
mTc-99
radionavigation surgery

How to Cite

Badaev , K. D., Novikov, S. N., Krzhivitsky , P. I., Levchenko, N. E., Yergnyan , S. M., Mamontov, O. Y., Khandogin , N. V., Yurin, R. I., Lopushanskaya, O. O., Shabinskaya, V. I., Murtazin, A. I., Valitova, A. A., & Levchenko, E. V. (2024). The original article Results of Using Intraoperative Sentinel Lymph Node Identification in the Surgical Management of Stage IA-IIA Non-Small Cell Lung Cancer. Voprosy Onkologii, 70(2), 308–315. https://doi.org/10.37469/0507-3758-2024-70-2-308-315

Abstract

Introduction. To evaluate the applicability, sensitivity and accuracy of the method of intraoperative determination of lymph flow pathways from the affected lobe and identification of sentinel lymph nodes in the surgical management of stage IA-IIA non-small cell lung cancer.

Materials and Methods. This prospective study has been conducted since November 2021 at the Department of Thoracic Oncology of the N.N. Petrov National Medical Research Centre of Oncology of the Ministry of Health of Russia. The study was approved by the local ethics committee № 1035 dated 08.10.2021. The analysis included 35 people.

Results. The SNLs were determined ex vivo in 34 of the 35 patients included in the study. In one case, it was not possible to reliably determine the radiopharmaceutical accumulation ex vivo and in the second and third points. According to the calculations, SLNs were identified in 97.14 % of cases. The number of patients with lymph node involvement was 5 out of 35. In five patients, metastatic lymph nodes were identified as sentinel lymph nodes. The accuracy of the method was 100 % (5 out of 5). The true negative rate was 30 out of 30 (100 %).

Conclusion. The results obtained using intraoperative peritumoral administration of radiopharmaceuticals to diagnose lymphatic flow and determine SLNs demonstrate the high accuracy of the method and warrant further study.

https://doi.org/10.37469/0507-3758-2024-70-2-308-315
##article.numberofdownloads## 54
##article.numberofviews## 210
pdf (Русский)

References

Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J Clin Wiley. 2018; 68(6): 394-424.-DOI: https://doi.org/10.3322/caac.21492.

Каприн А.Д. Состояние онкологической помощи населению России в 2022 году. Москва. 2023.

[Kaprin A.D. The state of oncological care for the population of Russia in 2022. 2023. (in Rus)].

Lv S., Wang Q., Zhao W., et al. A review of the postoperative lymphatic leakage. Oncotarget. 2017; 8(40): 69062-69075.-DOI: https://doi.org/10.18632/ONCOTARGET.17297.

Nakamura D., Toishi M., Sakaizawa T., et al. Postoperative chylothorax following lung cancer surgery with an aberrant course of thoracic duct: a case report. J Surg Case Reports. 2021; 2021(10).-DOI: https://doi.org/10.1093/JSCR/RJAB490.

Chida M., Minowa M., Karube Y., et al. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thorac Surg. 2009. 8(1): 89-92.-DOI: https://doi.org/10.1510/ICVTS.2008.193383.

Sano Y., Shigematsu H., Okazaki M., et al. Hoarseness after radical surgery with systematic lymph node dissection for primary lung cancer. Eur J Cardiothorac Surg. 2019; 55(2): 280-285.-DOI: https://doi.org/10.1093/EJCTS/EZY246.

Abughararah T.Z., Jeong Y.H., Alabbood F., et al. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study. Eur J Cardiothorac Surg. 2021; 59(4): 783-790.-DOI: https://doi.org/10.1093/EJCTS/EZAA369.

Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 1997; 111(6): 1718-1723.-DOI: https://doi.org/10.1378/CHEST.111.6.1718.

Toki M.I., Harrington K., Syrigos K.N. The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision making. Lung Cancer. 2020; 146: 127-133.-DOI: https://doi.org/10.1016/J.LUNGCAN.2020.04.026.

Wang Z., Cheng J., Huang W., et al. Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis. Ann Transl Med. 2021; 9(3): 218-218.-DOI: https://doi.org/10.21037/ATM-20-3513.

Sawabata N. Mediastinal lymph node staging for lung cancer. Mediastinum. 2019; 3.-DOI: https://doi.org/10.21037/MED.2019.07.04.

Fréchet B., Kazakov J., Thiffault V., et al. Diagnostic accuracy of mediastinal lymph node staging techniques in the preoperative assessment of nonsmall cell lung cancer patients. J Bronchology Interv Pulmonol. 2018;25(1): 17-24.-DOI: https://doi.org/10.1097/LBR.0000000000000425.

Billé A., Pelosi E., Skanjeti A., et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009; 36(3): 440-445.-DOI: https://doi.org/10.1016/J.EJCTS.2009.04.003.

Емельянов А.С., Криворотько П.В., Жильцова Е.К., и др. Хирургическое стадирование рака молочной железы с оценкой состояния аксиллярной области у пациенток категории сN+ перешедших в категорию ycN0 после неоадъювантной терапии. Вопросы онкологии. 2022. 68(3): 322-332.-DOI: https://doi.org/10.37469/0507-3758-2022-68-3-322-332.

[Yemelyanov A.S., Krivorotko P.V., Zhiltsova E.K., et al. Surgical staging of breast cancer with an assessment of the condition of the axillary region in patients of the cT+ category who switched to the hcT0 category after neoadjuvant therapy. Voprosy Onkologii = Problems in Oncology. 2022. 68(3): 322-332-DOI: https://doi.org/10.37469/0507-3758-2022-68-3-322-332. (in Rus)].

Семиглазов В.Ф., Жильцова Е.К., Криворотько П.В., и др. Опыт биопсии сигнальных лимфатических узлов после неоадъювантной химиотерапии. Вопросы онкологии. 2020; 66(4): 370-375.-DOI: https://doi.org/10.37469/0507-3758-2020-66-4-370-375.

[Semiglazov V.F., Zhiltsova E.K., Krivorotko P.V., et al. The experience of biopsy of sentineling lymph nodes after neoadjuvant chemotherapy. Voprosy Onkologii = Problems in Oncology. 2020; 66(4): 370-375.-DOI: https://doi.org/10.37469/0507-3758-2020-66-4-370-375. (in Rus)].

Криворотько П.В., Табагуа Т.Т., Комяхов А.В., и др. Биопсия сигнальных лимфатических узлов при раннем раке молочной железы: опыт НИИ онкологии им. Н.Н. Петрова. Вопросы онкологии. 2017; 63(2): 267-273.-DOI: https://doi.org/10.37469/0507-3758-2017-63-2-267-273.

[Krivorotko P.V., Tabagua T.T., Komyakhov A.V., et al. Biopsy of sentineling lymph nodes in early breast cancer : the experience of the N.N. Petrov National Medical Research Centre of Oncology. Voprosy Onkologii = Problems in Oncology. 2017; 63(2): 267-273.-DOI: https://doi.org/10.37469/0507-3758-2017-63-2-267-273. (in Rus)].

Николаева Е.А., Крылов А.С., Рыжков А.Д., и др. Диагностическая ценность методов радионуклидной визуализации сторожевого лимфатического узла при раке молочной железы. Сибирский онкологический журнал. 2022; 21(2): 12-23.-DOI: https://doi.org/10.21294/1814-4861-2022-21-2-12-23.

[Nikolaeva E.A., Krylov A.S., Ryzhkov A.D., et al. Diagnostic value of nuclear medicine modalities for the detection of sentinel lymph nodes in patients with breast cancer. Sib J Oncol. 2022; 21(2): 12-23.-DOI: https://doi.org/10.21294/1814-4861-2022-21-2-12-23. (in Rus)].

Чернышова А.Л., Ляпунов А.Ю., Коломиец Л.А., и др. Определение сторожевых лимфатических узлов при хирургическом лечении рака шейки матки. Сибирский онкологический журнал. 2012; 3(51): 29-33.

[Chernyshova A.L., Lyapunov A.Y., Kolomiets L.A., et al. Determination of sentinel lymph nodes in the surgical treatment of cervical cancer. Sib J Oncol. 2012; 3(51): 29-33. (in Rus)].

Очиров М.О., Кишкина А.Ю., Коломиец Л.А., и др. Биопсия сторожевых лимфатических узлов при хирургическом лечении рака эндометрия: история и современность. Опухоли Женской Репродуктивной Системы. 2018; 14(4): 65-71.-DOI: https://doi.org/10.17650/1994.

[Ochirov М.О., Kishkina A.Yu., Kolomiets L.A., et al. Sentinel lymph nodes biopsy in the surgical treatment of endome- trial cancer: history and present. Opukholi zhenskoy reproduktivnoy systemy = Tumors of female reproductive system. 2018; 14(4): 65-71.-DOI: https://doi.org/10.17650/1994. (in Rus)].

Афанасьев С.Г., Августинович А.В., Чернов В.И., и др. Возможности определения сторожевых лимфатических узлов у больных раком желудка. Сибирский онкологический журнал. 2009; 4(34).

[Afanasyev S.G., Avgustinovich A.V., Chernov V.I., et al. Radio-guided sentinel lymph node detection in gastric cancer patients. Sib J Oncol. 2009; 4(34). (in Rus)].

Чернышова А.Л., Ляпунов А.Ю., Чернов В.И., и др. Определение сторожевых лимфатических узлов при органосохраняющем лечении инвазивного рака шейки матки. Онкогинекология. 2017; 4: 47-55.

[Chernyshova A.L., Lyapunov A.Y., Chernov V.I., et al. Identification of sentinel lymph nodes in organ-preservation treatment of invasive cervical cancer. Oncogynegology. 2017; 4: 47-55. (in Rus)].

Brown M., Assen F.P., Leithner A., et al. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science. 2018; 359(6382): 1408-1411.-DOI: https://doi.org/10.1126/SCIENCE.AAL3662.

Matanes E., Gotlieb W.H. Pathophysiological and anatomical basis of lymphatic transit of cancer cells and role of the lymphatic system: a review of published literature. Chinese Clin Oncol. AME Publishing Company. 2021; 10(2): 14-14.-DOI: https://doi.org/10.21037/CCO-20-205.

Schraufnagel D.E. Lung lymphatic anatomy and correlates. Pathophysiol. 2010; 17(4): 337-343.-DOI: https://doi.org/10.1016/J.PATHOPHYS.2009.10.008.

Крживицкий П.И., Канаев С.В., Новиков С.Н., и др. Применение ОФЭКТ-КТ для визуализации сигнальных лимфатических узлов и путей лимфооттока у больных раком предстательной железы. Вопросы онкологии. 2016; 62(2): 272-276.-DOI: https://doi.org/10.37469/0507-3758-2016-62-2-272-276.

[Krzhivitsky P.I., Kanaev S.V., Novikov S.N., et al. The use of SPECT-CT to visualize sentineling lymph nodes and lymphatic drainage pathways in patients with prostate cancer. Voprosy Onkologii = Problems in Oncology. 2016; 62(2): 272-276.-DOI: https://doi.org/10.37469/0507-3758-2016-62-2-272-276. (in Rus)].

Канаев С.В., Новиков С.Н., Крживицкий П.И., и др. Применение офэкт-кт для визуализации сигнальных лимфатических узлов и путей лимфооттока у больных раком языка. Вопросы онкологии. 2019; 60(2): 51-56.-DOI: https://doi.org/10.37469/0507-3758-2019-65-2-250-255.

[Kanaev S.V., Novikov S.N., Krzhivitsky P.I., et al. The use of spect-CT for visualization of sentineling lymph nodes and lymphatic drainage pathways in patients with tongue cancer. Voprosy Onkologii = Problems in Oncology. 2019; 60(2): 51-56.-DOI: https://doi.org/10.37469/0507-3758-2019-65-2-250-255. (in Rus)].

Kim H.K., Kim S., Sung H.K., et al. Comparison between preoperative versus intraoperative injection of technetium-99 m neomannosyl human serum albumin for sentinel lymph node identification in early stage lung cancer. Ann Surg Oncol. 2012; 19(4): 1343-1349.-DOI: https://doi.org/10.1245/S10434-011-2130-4.

Sugi K., Fukuda M., Nakamura H., Kaneda Y. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer. 2003; 39(1): 37-40.-DOI: https://doi.org/10.1016/s0169-5002(02)00385-9.

Tiffet O., Nicholson A.G., Khaddage A., et al. Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest. 2005; 127(2): 443-448.-DOI: https://doi.org/10.1378/CHEST.127.2.443.

Passamonte P.M., Seger R.M., Holmes R.A., et al. Technetium-99m glucoheptonate imaging in lung cancer and benign lung diseases: concise communication. J Nucl Med. 1983; 24(11): 997-1000.

Jeong J.M., Hong M.K., Kim Y.J., et al. Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging. Nucl Med Commun. 2004; 25(12): 1211-1217.-DOI: https://doi.org/10.1097/00006231-200412000-00010.

Nomori H., Mori T., Ikeda K., et al. Segmentectomy for selected cT1N0M0 non-small cell lung cancer: a prospective study at a single institute. J Thorac Cardiovasc Surg. 2012; 144(1): 87-93.-DOI: https://doi.org/10.1016/J.JTCVS.2012.03.034.

Deng H.Y., Zhou J., Wang R.L., et al. Lobe-specific lymph node dissection for clinical early-stage (cIA) peripheral non-small cell lung cancer patients: what and how? Ann Surg Oncol. 2020; 27(2): 472-480.-DOI: https://doi.org/10.1245/S10434-019-07926-3.

Karamustafaoglu Y.A., Yoruk Y., Yanik F., et al. Sentinel lymph node mapping in patients with operable non-small cell lung cancer. J Thorac Dis. 2013; 5(3): 317-320.-DOI: https://doi.org/10.3978/J.ISSN.2072-1439.2013.06.01.

Kim S., Kim H.K., Kang D.Y., et al. Intra-operative sentinel lymph node identification using a novel receptor-binding agent (technetium-99m neomannosyl human serum albumin, 99mTc-MSA) in stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2010; 37(6): 1450-1456.-DOI: https://doi.org/10.1016/J.EJCTS.2010.01.012.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2024